Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroids vs steroids plus extracorporeal photopheresis for first-line treatment of grade II acute graft-versus-host disease
2017-005162-22Phase 2Terminated
- Sponsor
- CHRU Nancy
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methoxsalen in Acute Graft-Versus-Host Disease (aGvHD), sponsored by CHRU Nancy. Started Feb 2018; status: terminated.
02
Drugs
methoxsalen
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on 2017-005162-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005162-22.